{"id":{"repo_id":"utahstate","oai_identifier":"oai:digitalcommons.usu.edu:etd-1992"},"canonical_url":"https://search.ndltd.org/etd/utahstate/oai:digitalcommons.usu.edu:etd-1992","repository":{"repo_id":"utahstate","name":"Utah State University","base_url":"https://digitalcommons.usu.edu/do/oai/"},"display":{"title":"Does Non-Steroidal Anti-Inflammatory Drug (NSAID) Use Affect Dementia Progression and Survival Rates in Alzheimer's Disease? The Cache County Study","abstract":"Alzheimer's disease (AD) has multiple factors that contribute to the disease process. Among these is a state of chronic inflammation that is endured by the brain during the aging process. The use of non-steroidal anti-inflammatory drugs (NSAIDs) decreases the amount of neuroinflammation sustained by the brain, and greater levels of NSAID use have been demonstrated to be associated with decreased probability of developing AD. This study looked at whether greater rates of NSAID use were also associated with decreased rates of cognitive and funtional decline and survival in a population-based sample of persons with AD. Linear mixed models failed to find any association between any NSAID use, duration of use, or timing of use (before or after AD onset) and cognitive and functional outcomes. Cox regression models did not find any association between any NSAID use, NSAID use before or after AD onset, or duration of NSAID use and participant survival. The conclusion of this project is that NSAIDs do not affect AD progression or survival rates of persons with AD. These results are discussed within the scope of the current literature.","abstract_html":"Alzheimer&#x27;s disease (AD) has multiple factors that contribute to the disease process. Among these is a state of chronic inflammation that is endured by the brain during the aging process. The use of non-steroidal anti-inflammatory drugs (NSAIDs) decreases the amount of neuroinflammation sustained by the brain, and greater levels of NSAID use have been demonstrated to be associated with decreased probability of developing AD. This study looked at whether greater rates of NSAID use were also associated with decreased rates of cognitive and funtional decline and survival in a population-based sample of persons with AD. Linear mixed models failed to find any association between any NSAID use, duration of use, or timing of use (before or after AD onset) and cognitive and functional outcomes. Cox regression models did not find any association between any NSAID use, NSAID use before or after AD onset, or duration of NSAID use and participant survival. The conclusion of this project is that NSAIDs do not affect AD progression or survival rates of persons with AD. These results are discussed within the scope of the current literature.","abstract_has_math":false,"creators":["Buckley, Trevor R."],"institution":"Hosted by Utah State University Libraries","degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":"Psychology","degree_department":null,"school":null,"contributors":["JoAnn T. Tschanz","Heidi J. Wengreen","M. Scott DeBerard"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:46:41Z","subjects":["Alzheimer's Disease","Cognitive Decline","Dementia","NSAIDS","Survival Analysis","Psychiatry and Psychology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/cf58-70e5"],"render_values":[{"text":"https://doi.org/10.26076/cf58-70e5","href":"https://doi.org/10.26076/cf58-70e5","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usu.edu/etd/990","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usu.edu/etd/990","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usu.edu%3Aetd-1992","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["JoAnn T. Tschanz","Heidi J. Wengreen","M. Scott DeBerard"]},{"key":"dc:creator","label":"Author","values":["Buckley, Trevor R."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2011-08-09T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-12-01T08:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["Hosted by Utah State University Libraries"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Psychology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer's Disease","Cognitive Decline","Dementia","NSAIDS","Survival Analysis","Psychiatry and Psychology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usu.edu/etd/990"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/cf58-70e5"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Alzheimer's disease (AD) has multiple factors that contribute to the disease process. Among these is a state of chronic inflammation that is endured by the brain during the aging process. The use of non-steroidal anti-inflammatory drugs (NSAIDs) decreases the amount of neuroinflammation sustained by the brain, and greater levels of NSAID use have been demonstrated to be associated with decreased probability of developing AD. This study looked at whether greater rates of NSAID use were also associated with decreased rates of cognitive and funtional decline and survival in a population-based sample of persons with AD. Linear mixed models failed to find any association between any NSAID use, duration of use, or timing of use (before or after AD onset) and cognitive and functional outcomes. Cox regression models did not find any association between any NSAID use, NSAID use before or after AD onset, or duration of NSAID use and participant survival. The conclusion of this project is that NSAIDs do not affect AD progression or survival rates of persons with AD. These results are discussed within the scope of the current literature."]},{"key":"dc:description.note","label":"Dc Description Note","values":["<p>This work made publicly available electronically on August 9, 2011.</p>"]},{"key":"dc:title","label":"Title","values":["Does Non-Steroidal Anti-Inflammatory Drug (NSAID) Use Affect Dementia Progression and Survival Rates in Alzheimer's Disease? The Cache County Study"]}]}],"canonical_facts":{"dc:contributor":["JoAnn T. Tschanz","Heidi J. Wengreen","M. Scott DeBerard"],"dc:creator":["Buckley, Trevor R."],"dc:date.available":["2011-08-09T07:00:00Z"],"dc:date.created":["2011-12-01T08:00:00Z"],"dc:description.abstract":["Alzheimer's disease (AD) has multiple factors that contribute to the disease process. Among these is a state of chronic inflammation that is endured by the brain during the aging process. The use of non-steroidal anti-inflammatory drugs (NSAIDs) decreases the amount of neuroinflammation sustained by the brain, and greater levels of NSAID use have been demonstrated to be associated with decreased probability of developing AD. This study looked at whether greater rates of NSAID use were also associated with decreased rates of cognitive and funtional decline and survival in a population-based sample of persons with AD. Linear mixed models failed to find any association between any NSAID use, duration of use, or timing of use (before or after AD onset) and cognitive and functional outcomes. Cox regression models did not find any association between any NSAID use, NSAID use before or after AD onset, or duration of NSAID use and participant survival. The conclusion of this project is that NSAIDs do not affect AD progression or survival rates of persons with AD. These results are discussed within the scope of the current literature."],"dc:description.note":["<p>This work made publicly available electronically on August 9, 2011.</p>"],"dc:identifier":["https://digitalcommons.usu.edu/etd/990"],"dc:identifier.doi":["https://doi.org/10.26076/cf58-70e5"],"dc:publisher":["Hosted by Utah State University Libraries"],"dc:subject":["Alzheimer's Disease","Cognitive Decline","Dementia","NSAIDS","Survival Analysis","Psychiatry and Psychology"],"dc:title":["Does Non-Steroidal Anti-Inflammatory Drug (NSAID) Use Affect Dementia Progression and Survival Rates in Alzheimer's Disease? The Cache County Study"],"thesis:degree_discipline":["Psychology"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-11-19T08:46:41Z"}